Desonide Patent Expiration
Desonide is Used for treating mild to moderate atopic dermatitis in patients 3 months of age and older. It was first introduced by Padagis Us Llc
Desonide Patents
Given below is the list of patents protecting Desonide, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Verdeso | US8460641 | Microemulsion process and composition | Aug 13, 2027 | Almirall |
| Verdeso | US8962000 | Microemulsion and sub-micron emulsion process and compositions | Aug 31, 2025 | Almirall |
| Verdeso | US9492384 | Microemulsion and sub-micron emulsion process and compositions | Aug 31, 2025 | Almirall |
| Desonate | US6387383 | Topical low-viscosity gel composition |
Aug 03, 2020
(Expired) | Leo Pharma As |
| Verdeso | US6730288 | Mousse composition |
Sep 08, 2019
(Expired) | Almirall |
| Verdeso | US7029659 | Mousse composition |
Sep 08, 2019
(Expired) | Almirall |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Desonide's patents.
Latest Legal Activities on Desonide's Patents
Given below is the list recent legal activities going on the following patents of Desonide.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Year, Large Entity | 18 Apr, 2024 | US9492384 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 15 Apr, 2020 | US9492384 |
| Patent Issue Date Used in PTA Calculation Critical | 15 Nov, 2016 | US9492384 |
| Recordation of Patent Grant Mailed Critical | 15 Nov, 2016 | US9492384 |
| Email Notification Critical | 27 Oct, 2016 | US9492384 |
| Issue Notification Mailed Critical | 26 Oct, 2016 | US9492384 |
| Dispatch to FDC | 17 Oct, 2016 | US9492384 |
| Application Is Considered Ready for Issue Critical | 14 Oct, 2016 | US9492384 |
| Issue Fee Payment Received Critical | 13 Oct, 2016 | US9492384 |
| Issue Fee Payment Verified Critical | 13 Oct, 2016 | US9492384 |
Desonide's Family Patents
Explore Our Curated Drug Screens
Desonide Generic API Manufacturers
Several generic applications have been filed for Desonide. The first generic version for Desonide was by Galderma Laboratories Lp and was approved on Jun 15, 1988. And the latest generic version is by Alembic Pharmaceuticals Ltd and was approved on Dec 8, 2022.
Given below is the list of companies who have filed for Desonide generic, along with the locations of their manufacturing plants worldwide.
1. ALEMBIC
Alembic Pharmaceuticals Ltd has filed for 1 generic for Desonide. Given below are the details of the strengths of this generic introduced by Alembic.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.05% | cream | Prescription | TOPICAL | AB | Dec 8, 2022 |
Manufacturing Plant Locations New
Alembic's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Alembic as present at those locations.
| Country | City | Firm Name | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||||||
2. CADILA
Cadila Healthcare Ltd has filed for 1 generic for Desonide. Given below are the details of the strengths of this generic introduced by Cadila.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.05% | cream | Prescription | TOPICAL | AB | Nov 20, 2019 |
Manufacturing Plant Locations New
Cadila's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Cadila as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| United States |
| |||||
| India |
| |||||
3. CINTEX SVCS
Cintex Services Llc has filed for 1 generic for Desonide. Given below are the details of the strengths of this generic introduced by Cintex Svcs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.05%
(reference standard) | gel | Prescription | TOPICAL | N/A | May 11, 2020 |
4. COSETTE
Cosette Pharmaceuticals Inc has filed for 1 generic for Desonide. Given below are the details of the strengths of this generic introduced by Cosette.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.05% | cream | Prescription | TOPICAL | AB | Sep 28, 1992 |
Manufacturing Plant Locations New
Cosette's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Cosette as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| United States |
| |||||
5. ENCUBE ETHICALS
Encube Ethicals Pvt Ltd has filed for 1 generic for Desonide. Given below are the details of the strengths of this generic introduced by Encube Ethicals.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.05% | ointment | Prescription | TOPICAL | AB | Jan 30, 2019 |
Manufacturing Plant Locations New
Encube Ethicals's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Encube Ethicals as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| India |
| |||||
6. FOUGERA PHARMS
Fougera Pharmaceuticals Inc has filed for 1 generic for Desonide. Given below are the details of the strengths of this generic introduced by Fougera Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.05% | lotion | Prescription | TOPICAL | AB | Mar 19, 2002 |
7. GALDERMA LABS LP
Galderma Laboratories Lp has filed for 1 generic for Desonide. This 0.05% version comes by the name DESOWEN. Given below are the details of the strengths of this generic introduced by Galderma Labs Lp.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.05%
(reference standard) | lotion | Prescription | TOPICAL | AB | Jan 24, 1992 |
8. GLENMARK PHARMS LTD
Glenmark Pharmaceuticals Ltd has filed for 1 generic for Desonide. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.05% | ointment | Prescription | TOPICAL | AB | Sep 15, 2017 |
9. GLENMARK SPECLT
Glenmark Specialty Sa has filed for 1 generic for Desonide. Given below are the details of the strengths of this generic introduced by Glenmark Speclt.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.05% | lotion | Prescription | TOPICAL | AB | Sep 26, 2017 |
10. HIKMA
Hikma Pharmaceuticals Usa Inc has filed for 1 generic for Desonide. Given below are the details of the strengths of this generic introduced by Hikma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.05% | ointment | Discontinued | TOPICAL | N/A | Mar 27, 2017 |
Manufacturing Plant Locations New
Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||
| Portugal |
| |||||||||
| Jordan |
| |||||||||
11. PAI HOLDINGS PHARM
Pai Holdings Llc Dba Pharmaceutical Associates Inc has filed for 1 generic for Desonide. Given below are the details of the strengths of this generic introduced by Pai Holdings Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.05% | ointment | Discontinued | TOPICAL | N/A | Mar 12, 2019 |
12. TARO
Taro Pharmaceutical Industries Ltd has filed for 1 generic for Desonide. Given below are the details of the strengths of this generic introduced by Taro.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.05% | lotion | Prescription | TOPICAL | AB | Oct 31, 2014 |
Manufacturing Plant Locations New
Taro's manufacturing plants are situated in 3 countries - United States, Israel, Canada. Given below are the details of these plant locations as well as the firm names of Taro as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| United States |
| |||||
| Israel |
| |||||
| Canada |
| |||||